Skip to main content
Log in

Studies on mescaline XI: Biochemical findings during the mescaline-induced state with observations on the blocking action of different psychotropic drugs

  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Garattini, S., and Ghetti, V. (editors): Psychotropic Drugs. Elsevier and Company. Amsterdam. 1957.

  2. Marrazzi, A. S.: Psychosis as a function of disturbed chemical regulation of cerebral synaptic transmission. In: Chemical Concepts of Psychosis. M. Rinkel and H. C. B. Denber, editors, P. 305. McDowell, Obolensky. New York. 1958.

    Google Scholar 

  3. Denber, H. C. B., and Merlis, S.: Studies on mescaline V.: Antagonism between mescaline and chlorpromazine. In: Psychopharmacology, Publication No. 42, P. 141. American Association for the Advancement of science, Washington, D.C. 1956.

    Google Scholar 

  4. Denber, H. C. B.: Studies on mescaline III: Action in epileptics.Psychiat. Quart., 29:433, July 1955.

    PubMed  Google Scholar 

  5. Schwarz, E.; Bickford, R. G., and Rome, H. P.: Reversibility of induced psychosis with chlorpromazine. Proc. Staff Meet. Mayo Clin., 30:407, September 1955.

    Google Scholar 

  6. Hoch, P. H.: Psychoses-producing and psychoses-relieving drugs. In: The Brain and Human Behavior. A.R.N.D. P. 335. Williams and Wilkins. Baltimore. 1958.

    Google Scholar 

  7. Fabing, H. D.: Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis. Neurology, 5:319, May 1955.

    PubMed  Google Scholar 

  8. Denber, H. C. B.: Drug-induced states resembling naturally occurring psychoses. In: Psychotropic Drugs. S. Garattini and V. Ghetti, editors. P. 26. Elsevier and Company. Amsterdam. 1957.

    Google Scholar 

  9. Denber, H. C. B.: Studies on mescaline IX: Comparative action of various drugs on the mescaline-induced state. In: Biological Psychiatry. J. Masserman, editor. P. 203. Grune & Stratton. New York. 1959.

    Google Scholar 

  10. Denber, H. C. B.: Studies on mescaline VII: The role of anxiety in the mescaline-induced state and its influence on the therapeutic results. J. N. M. D., 124:74, July 1956.

    Google Scholar 

  11. Deniker, P.: Biological changes in man following intravenous administration of mescaline. J. N. M. D., 125:427, July–September 1957.

    Google Scholar 

  12. Bleuler, M.: Panel discussion. In: Neuro-Psychopharmacology, P. B. Bradley, P. Deniker, and C. Radouco-Thomas, editors. P. 161. Elsevier and Company. Amsterdam. 1959.

    Google Scholar 

  13. Troll, W., and Cannan, R. K.: A modified photometric ninhydrin method for the analysis of amino and imino acids. J. Biol. Chem., 200:803, February 1953.

    PubMed  Google Scholar 

  14. Zlatkis, A.; Zak, B. and Boyle, A. J.: A new method for the direct determination of serum cholesterol. J. Lab. Clin. Med., 41:486, March 1953.

    PubMed  Google Scholar 

  15. Denber, H. C. B., and Merlis, S.: Studies on mescaline VI: Therapeutic aspects of the mescaline-chlorpromazine combination. J. N. M. D., 122:463, November 1955.

    Google Scholar 

  16. Merlis, S.: The effect of mescaline sulfate in chronic schizophrenia. J. N. M. D., 125:432, July –September 1957.

    Google Scholar 

  17. Denber, H. C. B.: Studies on mescaline VIII: Psychodynamic observations. Am. J. Psychiat., 115:239, September 1958.

    PubMed  Google Scholar 

  18. Block, W.: Pharmacological aspects of mescaline. In: Chemical Concepts of Psychosis. M. Rinkel and H. C. B. Denber, editors. P. 106. McDowell, Obolensky. New York. 1958.

    Google Scholar 

  19. Mayer-Gross, W.; McAdam, W., and Walker, J.: Lysergsäure-diäthylamid und kohlenhydratstoffwechsel. Nervenarzt, 23:30, January 1952.

    PubMed  Google Scholar 

  20. Richter, D.: Biochemical aspects of schizophrenia. In: Schizophenia—Somatic Aspects. D. Richter, editor. P. 53. Macmillan. New York. 1957.

    Google Scholar 

  21. Georgi, F.; Honegger, C. G.; Jordan, D.; Rieder, H. P., and Rottenberg, N.: Investigations in protein metabolism in nervous and mental diseases with special reference to the metabolism of amines. Int. Rev. Neurobiol., 1:343, 1959.

    PubMed  Google Scholar 

  22. Grundy, S. M., and Griffin, A. C.: Relationship of periodic mental stress to serum lipoprotein and cholesterol levels. J.A.M.A., 171:1794, November 1959.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

These studies were carried out in the research division of Manhattan (N.Y.) State Hospital, and this report was presented at the symposium, “The Problem of Antagonists to Psychotropic Drugs,” Collegium Internationale Neuro-Psychopharmacologicum, Basle, Switzerland, July 4–7, 1960.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Denber, H.C.B. Studies on mescaline XI: Biochemical findings during the mescaline-induced state with observations on the blocking action of different psychotropic drugs. Psych Quar 35, 18–48 (1961). https://doi.org/10.1007/BF01572555

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01572555

Keywords

Navigation